Child R G, Osterberg A C, Sloboda A E, Tomcufcik A S
Arzneimittelforschung. 1980;30(4A):695-702.
100 analogs of gamma-oxo(1,1'-biphenyl)-4-butanoic acid (fenbufen) were prepared and tested using the carrageenin, polyarthritis, and UV erythema anti-inflammatory tests and the 2-phenyl-1,4-benzoquinone writhing and inflamed paw pressure analgesic tests. Only three retained the same full spectrum of activity as fenbufen: dl-4-(4-biphenyly)-4-hydroxybutyric acid, dl-4-(4-biphenylyl)-1,4-butanediol, and 4-biphenylacetic acid. Fenbufen had the same spectrum of activity as acetylsalicylic acid (ASA), phenylbutazone, and indometacin in the five tests. In addition, dose-response derived potencies show fenbufen more potent than ASA and at least as potent as phenylbutazone in all five tests.
制备了100种γ-氧代(1,1'-联苯)-4-丁酸(芬布芬)类似物,并使用角叉菜胶、多关节炎和紫外线红斑抗炎试验以及2-苯基-1,4-苯醌扭体和炎性爪压力镇痛试验进行测试。只有三种类似物保留了与芬布芬相同的全谱活性:dl-4-(4-联苯基)-4-羟基丁酸、dl-4-(4-联苯基)-1,4-丁二醇和4-联苯乙酸。在这五项试验中,芬布芬与乙酰水杨酸(ASA)、保泰松和吲哚美辛具有相同的活性谱。此外,剂量反应得出的效价表明,在所有五项试验中,芬布芬比ASA更有效,且至少与保泰松一样有效。